These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21338711)

  • 1. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis.
    Wilton SB; Leung AA; Ghali WA; Faris P; Exner DV
    Heart Rhythm; 2011 Jul; 8(7):1088-94. PubMed ID: 21338711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: a systematic review and meta-analysis.
    Yin J; Hu H; Wang Y; Xue M; Li X; Cheng W; Li X; Yan S
    Clin Cardiol; 2014 Nov; 37(11):707-15. PubMed ID: 25156448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy.
    Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM
    Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study to assess benefit of atrial rhythm control after cardiac resynchronization therapy and atrioventricular node ablation.
    Schwartzman D; Housel D; Bazaz R; Jain S; Saba S; Gorcsan J; Adelstein E
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):275-81. PubMed ID: 25431023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.
    Stavrakis S; Garabelli P; Reynolds DW
    Europace; 2012 Oct; 14(10):1490-7. PubMed ID: 22696519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strategy to achieve CRT response in permanent atrial fibrillation without obligatory atrioventricular node ablation.
    Himmel F; Reppel M; Mortensen K; Schunkert H; Bode F
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):943-7. PubMed ID: 22650352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
    Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
    JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
    Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
    Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of rate-controlled persistent atrial fibrillation with clinical outcome and ventricular remodelling in recipients of cardiac resynchronization therapy.
    Wilton SB; Kavanagh KM; Aggarwal SG; Philippon F; Yee R; Cowan K; Exner DV
    Can J Cardiol; 2011; 27(6):787-93. PubMed ID: 21908159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review.
    Ganesan AN; Brooks AG; Roberts-Thomson KC; Lau DH; Kalman JM; Sanders P
    J Am Coll Cardiol; 2012 Feb; 59(8):719-26. PubMed ID: 22340263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Schütte F; Lüdorff G; Grove R; Kranig W; Thale J
    Cardiol J; 2009; 16(3):246-9. PubMed ID: 19437399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations.
    Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G
    Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study).
    Tolosana JM; Hernandez Madrid A; Brugada J; Sitges M; Garcia Bolao I; Fernandez Lozano I; Martinez Ferrer J; Quesada A; Macias A; Marin W; Escudier JM; Gomez AA; Gimenez Alcala M; Tamborero D; Berruezo A; Mont L;
    Am J Cardiol; 2008 Aug; 102(4):444-9. PubMed ID: 18678303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in patients with atrial fibrillation: a meta-analysis.
    Lopes C; Pereira T; Barra S
    Rev Port Cardiol; 2014 Nov; 33(11):717-25. PubMed ID: 25457476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials.
    Bradley DJ; Shen WK
    Heart Rhythm; 2007 Feb; 4(2):224-32. PubMed ID: 17275763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation in Patients With Heart Failure: A Meta-Analysis of Randomised Controlled Trials.
    Virk SA; Bennett RG; Chow C; Sanders P; Kalman JM; Thomas S; Kumar S
    Heart Lung Circ; 2019 May; 28(5):707-718. PubMed ID: 30509786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy.
    Tolosana JM; Trucco E; Khatib M; Doltra A; Borras R; Castel MÁ; Berruezo A; Arbelo E; Sitges M; Matas M; Guasch E; Brugada J; Mont L
    Eur J Heart Fail; 2013 Dec; 15(12):1412-8. PubMed ID: 23845796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive impact of pulmonary vein isolation on biventricular pacing in nonresponders to cardiac resynchronization therapy.
    Fink T; Rexha E; Schlüter M; Lemes C; Maurer T; Heeger CH; Reissmann B; Rottner L; Tönnis T; Ujeyl A; Krüger M; Portz N; Wohlmuth P; Mathew S; Ouyang F; Rillig A; Kuck KH; Metzner A
    Heart Rhythm; 2019 Mar; 16(3):416-423. PubMed ID: 30273766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial.
    Plummer CJ; Frank CM; Bári Z; Al Hebaishi YS; Klepfer RN; Stadler RW; Ghosh S; Liu S; Mittal S
    Heart Rhythm; 2018 Mar; 15(3):369-375. PubMed ID: 29132930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.